UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma

Frontiers in immunology, 2020-08, Vol.11, p.1941-1941

2020

Volltextzugriff (PDF)

Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid‐Dependent Mechanism

Stem cells translational medicine, 2016-11, Vol.5 (11), p.1506-1514

2016

Volltextzugriff (PDF)

A phase IB/IIA study of ex vivo expanded allogeneic bone marrow–derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn’s disease

Surgery, 2024-02, Vol.175 (2), p.242-249

2024

Volltextzugriff (PDF)

Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin Lymphoma

Cancer discovery, 2022-08, Vol.12 (8), p.1886-1903

2022

Volltextzugriff (PDF)

MGMT enrichment and second gene co-expression in hematopoietic progenitor cells using separate or dual-gene lentiviral vectors

Virus research, 2015-01, Vol.196, p.170-180

2015

Volltextzugriff (PDF)

Repopulating defect of mismatch repair–deficient hematopoietic stem cells

Blood, 2003-09, Vol.102 (5), p.1626-1633

2003

Volltextzugriff (PDF)

In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning

The Journal of clinical investigation, 2003-11, Vol.112 (10), p.1561-1570

2003

Volltextzugriff (PDF)

Bone Marrow‐Derived Cells Exhibiting Lung Epithelial Cell Characteristics Are Enriched In Vivo Using Methylguanine DNA Methyltransferase‐Mediated Drug Resistance

Stem cells (Dayton, Ohio), 2008-03, Vol.26 (3), p.675-681

2008

Volltextzugriff (PDF)

Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipients

Molecular therapy, 2003-07, Vol.8 (1), p.42-50

2003

Volltextzugriff (PDF)

Cotransduction with MGMT and Ubiquitous or Erythroid-Specific GFP Lentiviruses Allows Enrichment of Dual-Positive Hematopoietic Progenitor Cells In Vivo

ISRN hematology, 2012, Vol.2012 (2012), p.1-12

2012

Volltextzugriff (PDF)

Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment

Stem cells international, 2016-01, Vol.2016 (2016), p.1-12

2016

Volltextzugriff (PDF)

Sequential single cell transcriptional and protein marker profiling reveals TIGIT as a marker of CD19 CAR-T cell dysfunction in patients with non-Hodgkin’s lymphoma

Cancer discovery, 2022-08, Vol.12 (8), p.1886-1903

2022

Volltextzugriff (PDF)

Retroviral Transduction of a Mutant Methylguanine DNA Methyltransferase Gene into Human CD34 Cells Confers Resistance to O6-benzylguanine Plus 1,3-bis(2-chloroethyl)-1-nitrosourea

Proceedings of the National Academy of Sciences - PNAS, 1996-11, Vol.93 (24), p.14088-14093

1996

Volltextzugriff (PDF)

Impact of Daratumumab on Stem Cell Collection, Graft Composition and Engraftment

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.S462-S463

2021

Volltextzugriff (PDF)

Human long-term culture initiating cells are sensitive to benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and protected after mutant (G156A) methylguanine methyltransferase gene transfer

Cancer gene therapy, 1999-07, Vol.6 (4), p.340-348

1999

Volltextzugriff (PDF)

282 - Dendritic Cell/Multiple Myeloma (MM) Fusion Vaccine with Lenalidomide Maintenance after Autologous Hematopoietic Cell Transplant (HCT) Induces MM-Specific Immunity, BMT CTN 1401

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S223-S224

2022

Volltextzugriff (PDF)

Dendritic Cell/Multiple Myeloma (MM) Fusion Vaccine with Lenalidomide Maintenance after Autologous Hematopoietic Cell Transplant (HCT) Induces MM-Specific Immunity, BMT CTN 1401

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S223-S224

2022

Volltextzugriff (PDF)

Safety of MGMT Gene Transfer into Hematopoietic Progenitors: A Phase I Clinical Trial Using Retroviral Gene Transfer of G156A MGMT To Protect Hematopoiesis during BG Plus Alkylating Agent Treatment of Advanced Malignancies

Blood, 2007-11, Vol.110 (11), p.500-500

2007

Volltextzugriff (PDF)

Improved Culture Expansion of Human Mesenchymal Stem Cells (MSCs) Using Fibroblastic Growth Factor-2 for the Treatment of Graft Versus Host Disease (GVHD)

Blood, 2007-11, Vol.110 (11), p.1207-1207

2007

Volltextzugriff (PDF)

Issues in Moving Gene Therapy Approaches to Early Clinical Trials

Gene Therapy of Cancer, 2014, p.493-501

Third Edition, 2014

Volltextzugriff (PDF)

Drug Selection Enrichment of Type II Pneumocytes Following Transplant of P140K MGMT Lentiviral Transduced Hematopoietic Stem Cells

Blood, 2004-11, Vol.104 (11), p.3594-3594

2004

Volltextzugriff (PDF)

Progressive Emergence of a Dominant Unit during Dual Unit Umbilical Cord Blood (UCB) Culture

Blood, 2005-11, Vol.106 (11), p.2191-2191

2005

Volltextzugriff (PDF)

Retrovirus Insertion Site Analysis Following In Vivo Drug Selection in a Phase I Clinical Trial Utilizing G156A MGMT for Enhanced Chemotherapy of Advanced Malignancies

Blood, 2005-11, Vol.106 (11), p.3048-3048

2005

Volltextzugriff (PDF)

Prophylactic Tocilizumab in Patients with Relapsed Refractory Lymphoma Treated with Anti CD19 Chimeric Antigen Receptor T-Cell Therapy

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.S275-S276

2020

Volltextzugriff (PDF)

1 – 25 von 212

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(158)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(212)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(90)
Ingenta
(75)
MEDLINE
(72)
NUS Single-Journal Subscriptions
(63)
Ovid
(62)
IngentaConnect Journals
(34)
Elsevier ScienceDirect Journals
(27)
Wiley Online Library
(26)
Wiley Online Library
(16)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(15)
JSTOR
(14)
ERIC
(13)
Ebook Central Perpetual and DDA
(11)
eBooks on EBSCOhost
(11)
Taylor & Francis Journals
(10)
Springer Journals
(9)
Taylor & Francis Journals
(9)
Taylor & Francis
(8)
Oxford journals
(7)
EBSCO_Psychology & Behavioral Sciences Collection
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma

Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid‐Dependent Mechanism

In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cells

A phase IB/IIA study of ex vivo expanded allogeneic bone marrow–derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn’s disease

Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin Lymphoma

MGMT enrichment and second gene co-expression in hematopoietic progenitor cells using separate or dual-gene lentiviral vectors

Repopulating defect of mismatch repair–deficient hematopoietic stem cells

In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning

Bone Marrow‐Derived Cells Exhibiting Lung Epithelial Cell Characteristics Are Enriched In Vivo Using Methylguanine DNA Methyltransferase‐Mediated Drug Resistance

Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipients

Cotransduction with MGMT and Ubiquitous or Erythroid-Specific GFP Lentiviruses Allows Enrichment of Dual-Positive Hematopoietic Progenitor Cells In Vivo

Antimicrobial Properties of Mesenchymal Stem Cells: Therapeutic Potential for Cystic Fibrosis Infection, and Treatment

Sequential single cell transcriptional and protein marker profiling reveals TIGIT as a marker of CD19 CAR-T cell dysfunction in patients with non-Hodgkin’s lymphoma

Retroviral Transduction of a Mutant Methylguanine DNA Methyltransferase Gene into Human CD34 Cells Confers Resistance to O6-benzylguanine Plus 1,3-bis(2-chloroethyl)-1-nitrosourea

Impact of Daratumumab on Stem Cell Collection, Graft Composition and Engraftment

Human long-term culture initiating cells are sensitive to benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and protected after mutant (G156A) methylguanine methyltransferase gene transfer

282 - Dendritic Cell/Multiple Myeloma (MM) Fusion Vaccine with Lenalidomide Maintenance after Autologous Hematopoietic Cell Transplant (HCT) Induces MM-Specific Immunity, BMT CTN 1401

Dendritic Cell/Multiple Myeloma (MM) Fusion Vaccine with Lenalidomide Maintenance after Autologous Hematopoietic Cell Transplant (HCT) Induces MM-Specific Immunity, BMT CTN 1401

Safety of MGMT Gene Transfer into Hematopoietic Progenitors: A Phase I Clinical Trial Using Retroviral Gene Transfer of G156A MGMT To Protect Hematopoiesis during BG Plus Alkylating Agent Treatment of Advanced Malignancies

Improved Culture Expansion of Human Mesenchymal Stem Cells (MSCs) Using Fibroblastic Growth Factor-2 for the Treatment of Graft Versus Host Disease (GVHD)

Issues in Moving Gene Therapy Approaches to Early Clinical Trials

Drug Selection Enrichment of Type II Pneumocytes Following Transplant of P140K MGMT Lentiviral Transduced Hematopoietic Stem Cells

Progressive Emergence of a Dominant Unit during Dual Unit Umbilical Cord Blood (UCB) Culture

Retrovirus Insertion Site Analysis Following In Vivo Drug Selection in a Phase I Clinical Trial Utilizing G156A MGMT for Enhanced Chemotherapy of Advanced Malignancies

Prophylactic Tocilizumab in Patients with Relapsed Refractory Lymphoma Treated with Anti CD19 Chimeric Antigen Receptor T-Cell Therapy

Suchergebnisse filtern